KLRA
Kailera Therapeutics Inc.

98
Mkt Cap
$2.78B
Volume
446,207.00
52W High
$28.23
52W Low
$16.00
Price
$21.47
KLRA Fundamentals
Prev Close
$22.47
Open
$22.52
50D MA
$23.76
Beta
0.00
Avg. Volume
1.73M
EPS (Annual)
-$1.76
Rev/Employee
$0.00
Loading...
Loading...

About

Kailera Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity. Its product candidate includes Ribupatide. The company was founded on May 08, 2024 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
145

Frequently Asked Questions

What is Market Cap of Kailera Therapeutics Inc.?
What is the 52-week high for Kailera Therapeutics Inc.?
What is the 52-week low for Kailera Therapeutics Inc.?
What is Kailera Therapeutics Inc. stock price today?
What was Kailera Therapeutics Inc. stock price yesterday?
What is the 50-day moving average of Kailera Therapeutics Inc.?
How many employees does Kailera Therapeutics Inc. have?

Latest KLRA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.